Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderRecruitingPhase 1 / Phase 22026-04-01NCT06721143

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AION Healthspan, Inc.1
George Clinical1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
SouthCoast Research Center, Inc.MiamiUnited States4
University of Miami, Leonard M. Miller School of MedicineMiamiUnited States2